Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06586424

The Prognostic Value of Anion Gap in Predicting Major Adverse Cardiovascular Events Among Patients With ST-Segment Elevation Myocardial Infarction

This study aims to evaluate the prognostic value of the anion gap in predicting major adverse cardiovascular events among patients with ST-segment elevation myocardial infarction. Researchers will collect information based on hospital registry as secondary data of in patient who had diagnosed as ST-segment elevation myocardial infarction and underwent primary percutaneous coronary intervention. The data consist of demographic data, clinical presentation, laboratory, and angiography result were collected from hospital registry by reviewing medical record. Then, the data was analyzed by using IBM SPSS Statistics v26.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

ST-segment Elevation Myocardial Infarction (STEMI) Cardiovascular Diseases Heart Diseases Infarction Ischemia Myocardial Infarction Myocardial Ischemia Necrosis Pathologic Processes Pathological Conditions, Signs and Symptoms ST Elevation Myocardial Infarction Vascular Diseases

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Dr. Kariadi Central General Hospital

Semarang, Central of Java, Indonesia

Location status: Recruiting

Location contact

Leo Deddy Pradipta

CONTACT

[email protected]

+6281316499074

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults with 18 - 70 years old with diagnosis of STEMI who underwent PPCI

Exclusion criteria

  • History of heart failure due to any causes
  • Cardiogenic shock before PPCI
  • Any infection at the time of presentation
  • Pregnant woman
  • Other causes of high anion gap levels such as chronic kidney disease, metabolic acidosis, etc

Treatment and study plan

Anion Gap

Diagnostic Test

Patient was taken blood examination before PPCI

Primary outcomes

  1. Major Adverse Cardiovascular Events (MACE)

    Time frame: During hospitalization, up to 1 weeks

Secondary outcomes

  1. Incidence of mortality

    Time frame: During hospitalization, up to 1 weeks

  2. Incidence of reinfarction

    Time frame: During hospitalization, up to 1 weeks

  3. Incidence of stroke

    Time frame: During hospitalization, up to 1 weeks

  4. Incidence of lethal arrhythmia

    Time frame: During hospitalization, up to 1 weeks

  5. Incidence of acute lung oedema

    Time frame: During hospitalization, up to 1 weeks

  6. Incidence of cardiogenic shock

    Time frame: During hospitalization, up to 1 weeks

Study contacts

Contact information is provided by the study sponsor or research team.

Leo Deddy Pradipta

CONTACT

[email protected]

+6281316499074

Sponsors and collaborators

Lead sponsor

Universitas Diponegoro

Other

Registry information

Acronym: ANGIO-STEMI

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Sep 19, 2024
Registry last updated
Sep 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.